Gene · 79054
Papers3,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cumulative pre-cooling methods do not enhance cycling performance in tropical climate. | PLoS One | 2023 | 37824451 | PubTator, text mining | PubMed |
| ABTB1 facilitates the replication of influenza A virus by counteracting TRIM4-mediated degradation of viral NP protein. | Emerg Microbes Infect | 2023 | 37823597 | PubTator, text mining | PubMed |
| Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis. | Comput Struct Biotechnol J | 2023 | 37822560 | PubTator, text mining | PubMed |
| Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens. | Cureus | 2023 | 37818504 | PubTator, text mining | PubMed |
| Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis. | Front Pharmacol | 2023 | 37808188 | PubTator, text mining | PubMed |
| Modulation of TRPM8 alters the phagocytic activity of microglia and induces changes in sub-cellular organelle functions. | Biochem Biophys Res Commun | 2023 | 37801990 | PubTator, text mining | PubMed |
| Target-based discovery of a broad spectrum flukicide. | bioRxiv | 2023 | 37790347 | PubTator, text mining | PubMed |
| CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer. | Cancer Biomark | 2023 | 37781794 | PubTator, text mining | PubMed |
Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal. | Pharmaceutics | 2023 | 37765310 | PubTator, text mining | PubMed |
A Systematic Review and Meta-Analysis of Free Triiodothyronine (FT3) Levels in Humans Depending on Seasonal Air Temperature Changes: Is the Variation in FT3 Levels Related to Nonshivering Thermogenesis? | Int J Mol Sci | 2023 | 37762355 | PubTator, text mining | PubMed |
| Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk. | Cancers (Basel) | 2023 | 37760496 | PubTator, text mining | PubMed |
| Myoglobin in Brown Adipose Tissue: A Multifaceted Player in Thermogenesis. | Cells | 2023 | 37759463 | PubTator, text mining | PubMed |
| Migraine: Advances in the Pathogenesis and Treatment. | Neurol Int | 2023 | 37755358 | PubTator, text mining | PubMed |
| Strong and aversive cold processing and pain facilitation in fibromyalgia patients relates to augmented thermal grill illusion. | Sci Rep | 2023 | 37749154 | PubTator, text mining | PubMed |
| Icilin, a cool/cold-inducing agent, alleviates lipopolysaccharide-induced septic sickness responses in mice. | Neurosci Lett | 2023 | 37742941 | PubTator, text mining | PubMed |
| Structural basis of the activation of TRPV5 channels by long-chain acyl-Coenzyme-A. | Nat Commun | 2023 | 37735536 | PubTator, text mining | PubMed |
| TRPM8 as a Potential Biomarker and Therapeutic Target for Gastric Cancer Identified by a Combination of Text Mining and RNA Sequencing. | Curr Gene Ther | 2023 | 37728085 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors. | Medicine (Baltimore) | 2023 | 37713832 | PubTator, text mining | PubMed |
| A new polymodal gating model of the proton-activated chloride channel. | PLoS Biol | 2023 | 37713449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79054/papers?page=17